Glenmede Trust’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,987
Closed -$458K 1337
2021
Q4
$458K Sell
5,987
-300
-5% -$26.5K ﹤0.01% 956
2021
Q3
$604K Sell
6,287
-4,162
-40% -$454K ﹤0.01% 848
2021
Q2
$1.11M Sell
10,449
-350
-3% -$34.4K 0.01% 674
2021
Q1
$967K Sell
10,799
-1,754
-14% -$193K 0.01% 691
2020
Q4
$1.26M Sell
12,553
-815
-6% -$60.8K 0.01% 607
2020
Q3
$652K Buy
13,368
+3,076
+30% +$148K ﹤0.01% 717
2020
Q2
$419K Buy
10,292
+10,275
+60,441% +$295K ﹤0.01% 810
2020
Q1
$0 Hold
17
﹤0.01% 3017
2019
Q4
$0 Buy
+17
New +$279 ﹤0.01% 3030

Other funds holding CRNC

Glenmede Trust's CRNC Position: Q1 2022 in Review

Glenmede Trust sold out of Cerence (CRNC) in Q1 2022, closing a stake of 5,987 shares — an estimated $458K sold.

Glenmede Trust first reported a position in CRNC in Q4 2019 and held it in 9 quarters. The position peaked at $1.26M in Q4 2020. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Glenmede Trust reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Glenmede Trust sold 5,987 Cerence shares in Q1 2022, an estimated $458K.
  • Glenmede Trust first reported a position in Cerence in Q4 2019 and held it in 9 quarters.
  • Glenmede Trust's Cerence position peaked at $1.26M in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Glenmede Trust's 13F filing for Q1 2022, filed 16 May 2022.